Market Analysis - Monthly Report - May, 2020 - Florfenicol

Factory

Capacity

Market

ZHEJIANG KANGMU PHARMACEUTICAL CO.,LTD

1100 MT

Kangmu's API has good quality, large market share and high acceptance. They are mainstream manufacturers of florfenicol. The factory basically does not directly conduct foreign trade, and most of them are through traders.

ANHUI LIBERTY PHARMACEUTICAL CO.,LTD

1500 MT

LIBERTY’s API, the main market is in South America, other markets will supply according to the actual output of the factory

Jiangsu Hansyn Pharmaceutical Co.,LTDPharmaceutical

1000 MT

Hansyn's API has very good quality, but the general price is higher than other similar products.

Factor

Explanation

Inventory

At present, manufacturers have little inventory pressure, and early orders have been delivered one after another. After June, orders are small, and subsequent inventory pressures are large.

Market Demand

Poor market demand, mainly pre-digested inventory has been digested.

Factory Mentality

Although the factory side still wants to maintain high prices, the downstream market has poor demand, the prices have been loosened, and the real single bargaining room

Upstream Raw Materials

D-P-METHYL SULFONE PHENYL ETHYL SERINATE (CAS:36983-12-7) ester, an important raw material for florfenicol, is currently stable in price, and D-ethyl ester determines the cost line of florfenicol.